Human Milk Oligosaccharides Shaping from Growth to Value - Abbott , Dupont Nutrition, Nestle, Royal DSM

The key players operating in the Human Milk Oligosaccharides (HMO) industry include Abbott Laboratories, BASF S.E., Biosynth Carbosynth, Chr. Prebiotics, such as fructooligosaccharides and galactooligosaccharides, are used in infant formula to prevent the growth of pathogenic Escherichia coli bacteria. The ability of breast milk to protect babies from infection and allergic reactions is expected to positively impact the market size, as human milk appears to provide long-term protection against obesity, hypertension, inflammation, diabetes, and heart disease in humans.

Get Sample Pages of the Report Before its Gone @ https://www.alliedmarketresearch.com/request-sample/12392

The introduction of new products is expected to reduce the impact of specific diseases such as diabetes and indigestion. According to distribution channel, the Human Milk Oligosaccharides (HMO )market is fragmented into hypermarkets & supermarkets, drug store or pharmacy, mass merchandiser, departmental stores, mono-brand stores, specialty stores, and online sales channel. It stimulates bacterial growth, particularly in the Bifidobacteriagenus, which aids in metabolic activity. At present, the current Human Milk Oligosaccharides (HMO) market trends indicate that the demand for HMOs is expected to grow at a significant rate in the coming years, due to the steady rise in number of health-conscious people around the world as well as increase in awareness about the benefits of HMOs. As a result, these functionally equivalent alternatives to HMOs are severely limiting market growth.

In 2020, the outbreak of the COVID-19 pandemic had an impact on the global Human Milk Oligosaccharides (HMO) market growth. During the lockdown, however, several brands have shifted their focus to e-commerce platforms to generate revenue and increase sales. Regionwise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. This is attributed to the fact that to drug store operators have emphasized convenience factors such as extended store hours and drive-through locations to attract and retain customers during increasing competition from mail-order retailers and supercenters.

Interested to Procure the Data? Inquire here at @ https://www.alliedmarketresearch.com/purchase-enquiry/12392

Owing to global concerns about poor nutrition and premature death, the demand for HMO in infant formula is accelerating market growth. This is also one of the Human Milk Oligosaccharides (HMO) market opportunity. Depending on application, the infant formula segment held the largest Human Milk Oligosaccharides (HMO) market share, as HMOs' beneficial properties such as memory formation and cognitive performance help in the growth and development of infants. Infant formula made from bovine milk, that is cow milk, contains less oligosaccharides than human milk. In this way, Human Milk Oligosaccharides (HMO) market analysis is done.

The third most abundant component of human milk is human oligosaccharides, which cannot be synthesized directly from human milk due to the donor group's scarcity. Consumption of these has been shown to improve infant gastrointestinal tract health by promoting the development of specific microorganisms in the intestinal micro flora. Ltd, Nestle Health Science, Royal DSM, and ZuChem.

Key findings of the study

The global Human Milk Oligosaccharides (HMO) market was valued at $125.9 million in 2020, and is projected to reach $332.6 million by 2028, registering a CAGR of 14.1% from 2021 to 2028.

Europe was the highest revenue contributor, accounting for $45.3 million in 2020, and is estimated to reach $124.1 million by 2028, with a CAGR of 14.6%.

By type, the 2'FL segment was the highest contributor to the market, with $42.3 million in 2020, and is estimated to reach $120.6 million by 2028, at a

CAGR of 14.6% during the forecast period.

On the basis of application, the infant formula segment was the highest contributor to the market, with $67.9 million in 2020, and is estimated to reach $191.7 million by 2028, at a CAGR of 14.5% during the forecast period.

In Europe, the UK was the highest revenue contributor with $12.5 million in 2020, and is estimated to reach $37.5 Million by 2028, registering a CAGR of 15.4%. Ash MOs are beneficial to the micro biome and immunity, key players are researching and developing new techniques, such as extracting HMO from cow milk using expensive techniques, or even generating them using microbes.

For Further Assistance Speak to Our Analyst @ https://www.alliedmarketresearch.com/connect-to-analyst/12392

Product launches, mergers & acquisitions, joint ventures, and geographical expansions are the key strategies adopted by players in the Human Milk Oligosaccharides (HMO) industry. While the global Human Milk Oligosaccharides (HMO) market remains competitive, market participants are expected to concentrate on packaging, pricing, and marketing strategies to gain a competitive advantage in the current market landscape.

The Human Milk Oligosaccharides (HMO) market segmentation is done on the basis of type, application, distribution channel, and region. This is attributed to the fact that HMOsexhibit prebiotic properties, the potential to improve memory & brain growth, and a high nutritional value. Some major manufacturers have already started to offer products in specific health and wellness categories, such as digestion and cognitive enhancement. Some of the nutritional effects of HMOs found in human milk can be recreated by commercially manufactured HMOs.

HMO market was valued at $125.9 million in 2020, and is estimated to reach $332.6 million by 2028, registering a CAGR of 14.1% from 2021 to 2028.

Human milk oligosaccharide (HMO) is a prebiotic that aids in the maintenance of human gut health. Owing to its antimicrobial and prebiotic properties, it can be used in a variety of foods, including pharmaceutical and medicinal foods as well as infant formulas.

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com
Allied Market Research Blog: https://blog.alliedmarketresearch.com

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions". AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.